Group One Trading’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $981 | Sell |
577
-247
| -30% | -$420 | ﹤0.01% | 1845 |
|
2025
Q1 | $1.68K | Hold |
824
| – | – | ﹤0.01% | 1692 |
|
2024
Q4 | $2.7K | Sell |
824
-1,336
| -62% | -$4.38K | ﹤0.01% | 1729 |
|
2024
Q3 | $5.94K | Hold |
2,160
| – | – | ﹤0.01% | 1343 |
|
2024
Q2 | $8.79K | Hold |
2,160
| – | – | ﹤0.01% | 1327 |
|
2024
Q1 | $14.5K | Hold |
2,160
| – | – | ﹤0.01% | 1214 |
|
2023
Q4 | $10.2K | Hold |
2,160
| – | – | ﹤0.01% | 1402 |
|
2023
Q3 | $9.05K | Hold |
2,160
| – | – | ﹤0.01% | 1417 |
|
2023
Q2 | $6.8K | Hold |
2,160
| – | – | ﹤0.01% | 1364 |
|
2023
Q1 | $9.61K | Sell |
2,160
-40
| -2% | -$178 | ﹤0.01% | 1331 |
|
2022
Q4 | $14.2K | Buy |
2,200
+650
| +42% | +$4.19K | ﹤0.01% | 1380 |
|
2022
Q3 | $20K | Sell |
1,550
-90
| -5% | -$1.16K | ﹤0.01% | 1439 |
|
2022
Q2 | $24K | Sell |
1,640
-1,015
| -38% | -$14.9K | ﹤0.01% | 1469 |
|
2022
Q1 | $99K | Sell |
2,655
-837
| -24% | -$31.2K | ﹤0.01% | 1236 |
|
2021
Q4 | $200K | Sell |
3,492
-150
| -4% | -$8.59K | ﹤0.01% | 1201 |
|
2021
Q3 | $372K | Buy |
3,642
+970
| +36% | +$99.1K | ﹤0.01% | 926 |
|
2021
Q2 | $261K | Buy |
2,672
+2,622
| +5,244% | +$256K | ﹤0.01% | 1016 |
|
2021
Q1 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 1699 |
|